Nanotheranostics in Prostate Cancer: Current Status and Future Potential

J Israr, R Ahmad, H Barkat, S Siddiqui - Nanotheranostics for Diagnosis …, 2024 - Springer
Prostate cancer is a common and serious disease that affects many men and unfortunately
leads to a high number of deaths among male cancer patients. Early detection and …

The Evolving Landscape of Prostate Cancer Care

Z Dlamini, R Hull, T Luvhengo, K Gaston - Transforming Prostate Cancer …, 2024 - Springer
Prostate cancer is the second most commonly diagnosed cancer in men, and GLOBOCAN
estimated that there were over 1.4 million newly diagnosed cases in 2020. The incidence of …

[PDF][PDF] 前列腺癌风险预测模型研究与应用分析——以数据驱动的视角

吴杰, 陈亚兰, 魏雪栋, 黄玉华, 侯建全, 林宇鑫 - 医学信息学杂志, 2024 - yxxxx.ac.cn
目的/意义回顾性分析前列腺癌风险预测模型的研究进展, 为前列腺癌智能化诊疗体系建设提供
参考. 方法/过程通过文献挖掘分析, 探讨分子, 影像, 个体, 群体等不同组学层次评价指标对 …

[PDF][PDF] PHYTOCHEMICAL AND SYNTHETIC INVESTIGATIONAL COMPOUNDS AS MODULATORS OF CYTOMETABOLIC AND CYTOSKELETAL DYNAMICS FOR …

SF De Silva - 2023 - harvest.usask.ca
Prostate cancer (PC) is the most commonly found malignancy among men globally. Many
genetic and epigenetic factors involving multiple cellular signaling networks are implicated …

Precision medicine insight into primary prostate tumor through transcriptomic data and an integrated systems biology approach

M Sadeghi, A Barzegar - Meta Gene, 2020 - Elsevier
The non-responsiveness towards the therapy of prostate tumors is due to an extreme
genetic heterogeneity including various tumor subpopulations depending on the genetic …

The Evolving Landscape of Prostate

Z Dlamini, R Hull, T Luvhengo - Transforming Prostate Cancer Care … - books.google.com
Prostate cancer is the second most commonly diagnosed cancer in men, and GLOBOCAN
estimated that there were over 1.4 million newly diagnosed cases in 2020. The incidence of …

[PDF][PDF] ПОЛІАМІНИ ПРИ РАКУ ПРОСТАТИ: ЗВ'ЯЗОК З АГРЕСИВНІСТЮ ПУХЛИН ТА РИЗИКОМ ПРОГРЕСУВАННЯ ЗАХВОРЮВАННЯ

СП Залєток, ОО Кленов, ВВ Бентрад… - researchgate.net
Змінений метаболізм є однією з ключових молекулярних характеристик раку
передміхурової залози (РПЗ). Пошук нових тканинних біомаркерів, які могли б слугувати …

[引用][C] PERMIT–PERsonalised MedicIne Trials

R Banzi, C Gerardi, V Pistotti - 2021